MentionFox
Home › funding signals › Sentonix, Inc.
Form D · on the record

Sentonix — $12.70M Form D filing, August 2026

Sentonix, Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-20.

Sentonix, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 20, 2026. The filing reports $12.70M sold. Its industry group is Pharmaceuticals. It names Karl Schmidt (COO), John Beaver (CEO), Kenan Turnacioglu (Secretary; Treasurer) (SEC Form D, August 20, 2026).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

3 more Pharmaceuticals raises in Massachusetts within 90 days ↓

Selling to Sentonix, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.

Is this your company?

Key facts

Run the free check on Sentonix, Inc. →

Sell to companies like Sentonix, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Sentonix, Inc.

New Form D on file · 2026-08-20 · the record

$12.70M
raise on the record
D
filing
17
investors in
MASSACHUSETTS
based
Open the record →

What the record says

FilingForm D
Filed2026-08-20
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inDELAWARE
Year formed2023
BasedARLINGTON, MASSACHUSETTS
CIK2039609
Accession0002039609-26-000003

Pitching, partnering or investing alongside them? See who really runs and owns Sentonix, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Sentonix, Inc., from the filings we hold.

More raises like this

Pharmaceuticals raises by companies based in Massachusetts, filed within 90 days of this one, largest first.

What do you want to do with Sentonix, Inc.?

Get the full cited report on Sentonix, Inc.

What the filing shows about Sentonix, Inc.

  • 17 investors had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Sentonix, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Sentonix, Inc.'s address as 1167 Massachusetts Ave, Arlington, MA 02476.

What the filing says

  • Offered: $21,203,719. Sold: $12,704,719. Left to sell: $8,499,000. (filing)
  • Investors: 17 had already invested. (filing)
  • Date of first sale: August 13, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • Securities that converted: the filing says “Total Offering Amount and Total Amount Sold includes conversion of $11,203,719.19 in convertible promissory notes for which a Form D was previously filed on October 3, 2024.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Sentonix, Inc. See pricing

Is Sentonix, Inc. a real, registered company?

Sentonix, Inc. is a registered filer with the SEC (CIK 2039609) and has filed since 2024-10-03. 2 filings are on record, the latest on 2026-08-20.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Sentonix, Inc.?

Sentonix, Inc.'s Form D of 2026-08-20 names Karl Schmidt, John Beaver, Kenan Turnacioglu and 1 more as its officers, directors or promoters.

How much has Sentonix, Inc. raised?

Its new offerings report $17.91M sold across 2 offerings, as its own filings state.

Filing history · 3 filings on this registrant
Form D · 2024-10-03 · $5.21MForm D/A, amended · 2025-05-12 · $6.50MForm D · 2026-08-20 · $12.70M · this page 2024-10-03 2026-08-20

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Pharmaceuticals · by week
This raise, $12.70M, filed week of Aug 17

Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $12.70M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Sentonix, Inc.?

What the filing shows about Sentonix, Inc.

  • 17 investors had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Sentonix, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Sentonix, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Sentonix, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Sentonix, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Sentonix, Inc.: Raised $12.70M, Form D filed 2026-08-20
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/sentonix-inc-form-d-26000003
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Sentonix raised $12.70M — SEC Form D filing, August 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/sentonix-inc-form-d-26000003